CDC advisers finally admit that much-hyped FluMist doesn’t work

The U.S. government just pulled a $200 million con on millions of Americans.

The CDC has issued a warning that one of the most common flu vaccines around doesn’t work.

In fact, it’s about as useful as a box of rocks.

But there’s one very important piece of information the CDC left out of its alert.

They’ve known about the problem for more than a year — and there’s only one reason they waited until after flu season to clue everybody in.

The $200 million-dollar dud

With summer here, the flu — and the flu vaccine, for that matter — may be the furthest things from your mind.

And, trust me, that’s exactly what the CDC is hoping. Because the admission they just made is the kind of thing they wanted to do as quietly as possible.

Turns out that one of the CDC’s most sacred of sacred cows — the FluMist nasal spray flu vaccine — doesn’t stop flu.

Gee, it certainly took them long enough to figure that one out. Because I told you that very same thing around a year-and-a-half ago!

Late in 2014 I discovered three, yes three, studies showing that FluMist was a dud. And one of those came right from AstraZeneca, the company that makes the vaccine.

Not only did the CDC know full well about this research, but another one of those studies came from the agency itself. All I heard at the time was that CDC personnel were “sitting around, scratching their heads.”

Well, I’m scratching my head, too. I mean it’s unbelievable that they just got around to telling us this.

And, trust me, there’s only one reason for it. Our government spends a fortune stockpiling and promoting flu vaccines — and they weren’t about to do anything to harm sales during flu season.

That’s absolutely outrageous. And it’s another reason why we shouldn’t trust a word from the government as far as flu vaccines are concerned.

The CDC’s Advisory Committee on Immunization Practices is now saying we shouldn’t bother with FluMist, which is approved for people between the ages of 2 and 49. Of course, that doesn’t help all the people who already got it.

As you can imagine, AstraZeneca wasted no time in issuing a press release saying that it still believes the vaccine is effective and it’s “working with the CDC to better understand its data.” Also, that it’s going to take an “inventory write-down” of around $80 million because of this.

But don’t expect this news to put a dimmer switch on the flu-shot frenzy that will be coming around again this fall. As I’ve said, the vaccine business (flu shots especially), is a great one to be in.

You don’t have to guarantee your product works, the feds will help you sell it, and you have absolutely no liability when it harms someone. That’s why AstraZeneca made $200 million on FluMist last year alone.

Nice work if you can get it!

But seriously, flu shots, whether they go up your nose or are injected into your arm, come with a whole host of side effects that drugmakers and their minions at the CDC would prefer you never heard about.

Take, for example, the Fluzone High-Dose shot being pitched to seniors.

After being approved by the FDA, the manufacturer reported side effects such as low platelet counts, enlarged lymph nodes, life-threatening allergic reactions, extreme shoulder pain and paralysis, Guillain-Barre syndrome and convulsions.

And to top it all off, several years ago, a large analysis of studies done over four decades found that when influenza was confirmed, flu shots only “provide moderate protection” at best.

Look, we know that a flu vaccine doesn’t have to work for the mainstream to push it. So for all we know FluMist may circle back around later this year as the greatest thing since sliced bread.

The bottom line regarding the flu is to do all you can to keep your immune system in tip-top shape. Wash your hands frequently, take a probiotic, and load up on zinc.

And remember that, when it comes to flu vaccines, lots of times we don’t learn that they’re lemons until it’s too late.

Sources:
“CDC panel recommends against using FluMist vaccine” Susan Scuttl, June 23, 2016, CNN, cnn.com